Background-Full recovery is always achieved after caerulein induced pancreatitis. Cyclosporin stimulates transforming growth factor (TGF-) and may interfere with pancreatic regeneration. Aim-To investigate the eVects of cyclosporin after caerulein induced pancreatitis or after caerulein injury. (Gut 1999;45:269-277) 
Caerulein hyperstimulation induces acute oedematous pancreatitis in rats. Despite morphological and biochemical evidence of pancreatic injury, complete recovery is the rule. Restoration of normal pancreatic architecture and function after caerulein induced pancreatitis involves controlled and transient increases in transforming growth factor factor (TGF-), fibroblast proliferation, collagen formation, and activation of tissue proteinases. The reparative process is so highly coordinated that scarring, signs of atrophy, inflammatory cells, or distortion of pancreatic morphology cannot be recognised a few days after the caerulein challenge. [1] [2] [3] [4] [5] [6] Moreover, even repeated bouts of caerulein induced pancreatitis fail to cause permanent damage to the pancreas, 7 indicating that either the injury is not severe enough to overcome a number of non-specific tissue defences or that highly eYcient regenerative mechanisms are activated. Nonetheless, experimental manipulations, such as infusion of TGF- 8 or stress 9 , may disrupt the reparative sequence and result in defective regeneration.
Cyclosporin is widely used in clinical practice, particularly to prevent rejection of organ transplantation. It binds to cyclophilin and inhibits calcineurin, a serine-threonine phosphatase. 10 This property may account for its wide biological actions such as immunosuppression, vasoconstriction, 11 and stimulation of TGF-expression. [12] [13] [14] Although cyclosporin accumulates in high concentrations in the pancreas, [11] [12] [13] [14] [15] it only produces minor morphological or functional derangements. 16 17 Even after several days of a large dose regimen, cyclosporin does not induce an acute inflammatory reaction over the pancreas. 17 In the kidneys, heart, and gums, cyclosporin is known to promote collagen deposition. [18] [19] [20] In the present study we tested the hypothesis that, in the pancreas, cyclosporin exerts its fibrogenic potential by interfering with the highly eYcient reparative processes that are activated after caerulein hyperstimulation, resulting in poor gland regeneration and enhanced collagen deposition.
Materials and methods

MATERIALS
Caerulein, hydroxyproline, azocoll, calf thymus DNA standards, Hoechst compound 33258 (bisBenzimide) and anti-smooth muscle -actin (SMA) monoclonal antibody were from Sigma. BCA reagent and bovine serum albumin standard for protein determination were from Pierce (Rockford, Illinois, USA). Labelled streptavidin-biotin (LSAB) kit was from Dako Corporation (Carpinteria, CA, USA). Cyclosporin was from Sandoz Pharma SAE (Barcelona, Spain).
TGF-1 test kit was from Genzyme (Cambridge, Massachusetts, USA).
METHODS
All experiments were performed on 300 g male Wistar rats housed in rack mounted cages under conditions of constant temperature and a 12 hour lighting cycle.
Experimental procedures
To examine the eVects of cyclosporin on pancreatic regeneration after acute oedematous pancreatitis, two main protocols were followed (fig 1) . In protocol A we evaluated the early cyclosporin induced events after acute oedematous pancreatitis (fig 1) . Intraperitoneal daily doses of cyclosporin (20 mg/kg diluted 1:4 in saline) were administered for 15 days. On days 1 and 8, acute pancreatitis was induced by four intraperitoneal injections of caerulein (20 µg/kg) one hour apart (CR+CsA group). Three other groups followed the same experimental procedure except that they received caerulein (CR group), cyclosporin (CsA group) or vehicle (control group) alone. In each experimental condition, groups of 12 rats were killed on days 3, 7, 11 and 15 and pancreata were excised for histopathological examination (n = 6) or for biochemical assays (n = 6). Before the animals were killed, blood was withdrawn by cardiac puncture using heparinised syringes, and plasma was obtained for TGF-1 determination.
In protocol B we evaluated cyclosporin induced long term accumulation of fibrotic tissue under milder conditions (fig 1) . At weekly intervals, six episodes of acute pancreatitis were induced in rats by intraperitoneal administration of only two doses of caerulein (10 µg/kg) one hour apart. Cyclosporin (20 mg/kg) was given intraperitoneally the day before and the same day that pancreatitis was induced. For the next five days (until the next pancreatitis induction) rats received no further treatment. After the last induction, rats were allowed to recover for two weeks except for a single weekly dose of cyclosporin. Pancreata were then excised, weighed, and processed either for light microscopy or for biochemical assays (CR+CsA group). Three other groups of rats followed the same treatment protocol except that they received vehicle, cyclosporin, or caerulein alone (n = 12 per group).
Morphology
Pancreatic specimens were fixed in 10% formalin and embedded in paraYn wax. Several sections were cut and stained with haematoxylin-eosin or Masson trichrome stain. When indicated, immunohistochemistry was performed with the monoclonal anti-SMA antibody ( -SMA) to identify myofibroblasts (interstitial -SMA positive cells with fibroblast-like shape) using the avidin-biotinperoxidase complex system (LSAB kit, Dako Corporation). Quantitative analysis of interstitial -SMA positive cells was performed at 400 × final magnification. Ten non-overlapping fields were evaluated for each animal in each treatment group.
Histological slides were examined by the participating pathologist (AS) who was unaware of the tissue source.
Biochemical determinations
For biochemical assays, total pancreata were excised, trimmed of fat and lymph nodes, weighed, frozen, and lyophilised. A powder was made in a mortar from the dried residue and resuspended in ice cold distilled water (100 mg/ml). Pancreatic homogenates were prepared by serial use of a motor driven shearer (Tissue Tearor 985-370; Biospec Products Inc, Drewel, Wisconsin, USA) and Dounce tissue homogenisers on ice.
Total protein and hydroxyproline content were quantified from crude homogenates. Protein concentration was determined by BCA reagent.
Hydroxyproline content was determined as described 21 22 with minor modifications. Briefly, an aliquot of 200 µl of crude homogenate was placed in a 10 ml ampoule containing 2 ml 6 M HCl and sealed. Hydrolysis was performed at 110°C for 16 hours. The hydrolysate was dried, and the sediment redissolved in 2 ml distilled water and dried again. The latter step was repeated three times before the residue was resuspended in 3 ml 0.2 M citrate buVer (pH 2.2). A 1 ml portion of the sample or 1 ml of hydroxyproline standards (to establish the calibration curve) was placed in a Pyrex test tube and mixed with 1 ml chloramine T solution prepared as described by Rojkind and Gonzalez. 21 After a 20 minute incubation period, the reaction was stopped by the sequential addition of 0.5 ml sodium thiosul- phate (2 M), 1 ml NaOH (1 M), and 2 g NaCl. Proline was extracted in 2.5 ml toluene by shaking the contents for 30 seconds. The aqueous fraction was placed in a boiling water bath for 30 minutes and cooled to room temperature. Hydroxyproline was extracted in 2.5 ml toluene and determined by the use of Ehrlich's reagent.
In these experiments we measured total biologically active collagenases in crude homogenates by a method that uses a collagen bound dye (azocoll) as substrate 23 with minor modifications. Briefly, 0.25 g of the insoluble collagen-dye conjugate azocoll was suspended in 50 ml 50 mM Tris/HCl/1 mM CaCl 2 (pH 7.8) and stirred for 10 minutes. Azocoll was then allowed to sediment, the supernatant discharged, and the sediment resuspended in the same buVer containing aprotinin (140 µg/ml) to prevent azocoll hydrolysis by other pancreatic proteases. 24 Crude homogenates were sonicated before DNA measurement. Total DNA was assayed as described 25 by incubating 20 µl of sonicated tissue homogenates with Hoechst compound 33258 (1 µg/ml final concentration) in phosphate/saline buVer (0.05 M NaPO 4 , 2 M NaCl, pH 7.4) for 30 minutes. Fluorescence measurements were made using an SFM 25 fluorimeter (Tegimenta AG, Rotkreuz, Switzerland), setting the excitation light to 356 nm and the emission light to 458 nm. The DNA concentration of each sample was calculated from extrapolation on a standard curve constructed with calf thymus DNA.
To measure biologically active TGF-1 concentration in plasma, samples and standards were acidified using HCl for one hour and then neutralised to pH 7.0-7.4 before the enzyme linked immunosorbent assay.
Assessment of pancreatitis severity
To elucidate whether or not cyclosporin worsened the oedematous acute pancreatitis induced by caerulein, we measured amylasaemia, tissue oedema, and myeloperoxidase activity six hours after inducing acute pancreatitis. A specimen from the head of the pancreas was also processed for histological examination. Amylase activity was determined by the -amylase EPS test (Boehringer) for BM/ Hitachi system 717. Aliquots (200 µl) of 1:800 dilutions of the sample were used in the assay.
To measure pancreatic oedema, excised pancreata were wet weighed, desiccated at 160°C for 24 hours, and reweighed. Pancreatic water content was calculated as percentage of total wet weight.
Tissue myeloperoxidase activity was used as a biochemical marker of polymorphonuclear infiltration. It was measured in pancreatic homogenates using a previously described method 26 27 that measures myeloperoxidase activity as the result of H 2 O 2 dependent oxidation of 3,3',5,5'-tetramethylbenzidine and expressed as units per mg of protein.
Statistical analysis
Values are expressed as mean (SEM). Student's t test was used when two variables were compared. When more than two variables were present, group means were compared by analysis of variance followed by Fisher's protected least significant diVerences test. Differences were regarded as significant at p<0.05.
Results
PROTOCOL A: EFFECTS OF DAILY CYCLOSPORIN TREATMENT ON THE EARLY PHASE OF PANCREATIC REGENERATION
Cyclosporin treatment did not aggravate caerulein induced pancreatitis, as assessed by serum amylase (45.7 (6.9) v 70.7 (13.7) U/ml; p = 0.12), tissue oedema (83.2 (2.3) v 87.1 (0.7)%; p = 0.4), and myeloperoxidase activity (311 (54) v 344 (70) mU/mg protein; p = 0.8). Furthermore, contrary to previous reports, 28 no haemorrhages could be identified in pancreata from rats receiving the combined treatment of cyclosporin plus caerulein, by either macroscopic or microscopic inspection.
Plasma TGF-concentration
In close agreement with previous reports in humans and mice, 13 14 plasma levels of TGFin rats treated with cyclosporin were found to be well above control values of 19 (3) ng/ml, in both the CR+CsA and CsA groups (fig 2) . TGF-also increased, but to a lesser extent, in the CR group but had returned to baseline values by the end of the observation period.
Hydroxyproline concentration and collagenase activity in pancreatic homogenates
Tissue hydroxyproline increased soon after pancreatitis in the CR group. This enhancement in collagen formation was matched by a reciprocal increase in pancreatic collagenase activity, and both remained slightly elevated in response to a second induction of pancreatitis (fig 3) . In contrast, tissue collagenase in the CR+CsA group was low after pancreatitis, despite an elevated hydroxyproline content, but increased with time and became very high by the end of the observation period in the face of increased tissue hydroxyproline concentration (fig 3) , which suggests defective extracellular matrix remodelling. Pancreatic weight and total protein Both variables are widely used to quantify pancreatic gland atrophy. Pancreatic weight and protein content decreased after each bout of pancreatitis in the caerulein alone group, but recovered thereafter (fig 4) . In contrast, when rats also received cyclosporin, pancreatic weight and protein decreased further and did not recover. Cyclosporin alone had no measurable eVects after 15 days of treatment on pancreatic weight or total protein content (3.2 (0.1) g/kg body weight and 102 (5.2) mg) as compared with saline (3.2 (0.2) and 97 (10); p>0.05 for both variables).
Morphological findings
At the end of the observation period, neither cyclosporin nor caerulein alone had produced significant alterations in pancreatic structure. Loose connections between adjacent acini, a certain degree of fat atrophy, and some cells with cytoplasmic vacuolisation could be observed after cyclosporin, and, two weeks after the initial caerulein challenge, pancreatic morphology in the caerulein alone group was grossly restored, except for occasional inflammatory infiltrates ( fig 5) . In contrast, pancreatic specimens from the CR+CsA group showed diVuse infiltration with inflammatory mononuclear and polynuclear cells, surrounding areas of gland atrophy. There was also increased connective tissue and fine bands of collagen that were best visualised by Masson trichromic staining (data not shown).
Fibroblast-like cells immunoreactive for -SMA have contractile capabilities and are considered to be myofibroblasts. Immunostaining with anti--SMA allowed quantification of myofibroblasts in pancreatic parenchyma ( fig 6) . Normal pancreatic tissue contained no interstitial cells exhibiting immunoreactivity for -SMA. At the end of the observation period in the caerulein alone group, myofibroblasts (interstitial -SMA immunoreactive cells) displayed an elongated shape and could be observed scattered among well structured acini throughout the parenchyma of the pancreas ( fig 6B) . In the CR+CsA group, myofibroblasts were significantly increased in number compared with the CR group (figs 6D and 7). They were mainly distributed in association with areas of excess connective tissue accumulation and inflammatory cell infiltrates. Interestingly, in the pancreas of rats receiving cyclosporin alone, myofibroblasts were also a prominent feature on morphological inspection (figs 6C and 7). They were increased in number as compared with controls and were found evenly distributed in parenchyma with minimal structural disturbances and no inflammatory infiltrates.
Figure 4 EVects of cyclosporin on recovery of pancreatic weight and protein content after caerulein induced pancreatitis (protocol A). Induction of caerulein pancreatitis substantially reduced pancreatic weight and protein content. Addition of cyclosporin resulted in a continuous fall in pancreatic weight and protein and precluded recovery as measured by these two markers of atrophy. *p<0.05 v caerulein + cyclosporin. Arrows denote episodes of pancreatitis induction.
PROTOCOL B: EFFECTS OF WEEKLY PULSES OF CYCLOSPORIN ON LONG TERM PANCREATIC RECOVERY AFTER REPEATED BOUTS OF CAERULEIN INDUCED PANCREATITIS
The main aim of this protocol was to assess the persistence of pancreatic collagen deposition generated by cyclosporin, administered by a weekly pulse regimen in association with repeated bouts of oedematous acute pancreatitis.
Figure 5 Histological features of the pancreas 15 days after initiation of protocol A schedule (two pancreatitis inductions one week apart). (A) Caerulein alone group (haematoxylin and eosin stain; original magnification × 200). (B) Caerulein + cyclosporin group (haematoxylin and eosin stain; original magnification × 250). Pancreas from the caerulein alone group had a normal appearing parenchyma with occasional discrete mononuclear infiltrates. Specimens from the caerulein + cyclosporin group showed evident signs of persistent tissue damage such as increased connective tissue deposition associated with diVuse lymphomononuclear infiltrates and areas of gland atrophy.
Figure 6 Representative examples of pancreatic specimens from controls (A), caerulein alone (B), cyclosporin alone (C) or caerulein + cyclosporin(D) groups as seen after immunostaining for smooth muscle -actin (SMA). The antibody binds to cells in the vessel walls (A). No immunoreactive interstitial cells were identified in controls
Once again, cyclosporin was the inducer of an inappropriate regenerative pancreatic response. Biochemical markers of gland atrophy such as pancreatic weight, total protein, and DNA content were all significantly reduced in the group of rats receiving the combination regimen, even after two weeks of the last bout of pancreatitis (fig 8) . Furthermore, collagen deposition was greatly enhanced in this group as measured by tissue hydroxyproline concentration (fig 8) and examination of the histological appearance (fig 9) . Indeed, two weeks after the last pancreatitis induction there was appreciable atrophy of peripancreatic fat, areas of gland atrophy, and large bundles of fibrosis with diVuse lymphomonocytic infiltrates and proliferation of fibroblasts. Fine bands of fibrotic tissue extended inside the better preserved lobuli, indicating a generalised fibrotic process.
These findings contrasted with the absence of substantial morphological or biochemical abnormalities in groups of rats treated with either cyclosporin or caerulein alone.
Discussion
In this paper we describe the transformation of a highly eYcient and well coordinated process of tissue repair-that is, regeneration after caerulein induced pancreatitis-into chroniclike pancreatitis featuring gland atrophy, persistent mononuclear infiltrates, and enhanced collagen deposition, all under the influence of a single pharmacological manipulation.
Cyclosporin interfered with pancreatic regeneration even when it was administered at weekly pulse doses (protocol B), noteworthy, without concurrence of any surgical interventions or anaesthetics. The latter may be a critical point as pentobarbital and other anaesthetics inactivate or inhibit the action of nitric oxide 29 and therefore may reduce splanchnic blood flow. 30 Cyclosporin also reduces pancreatic blood flow, 31 and consequently the combination of cyclosporin and anaesthetics may well potentiate damage to the gland.
Cyclosporin did not aggravate the severity of caerulein induced acute pancreatitis based on factors such as amylasaemia, tissue oedema, 
Figure 8 EVects of cyclosporin on a limited dose regimen (given before pancreatitis induction) on pancreatic recovery and collagen deposition two weeks after six weekly courses of caerulein induced pancreatitis (protocol B). Concurrent administration of cyclosporin significantly reduced pancreatic weight, total protein, and DNA content, indicating a higher degree of gland atrophy compared with rats receiving caerulein alone. In addition, hydroxyproline concentration was largely increased in the pancreas of rats receiving the combined treatment (cyclosporin + caerulein). * p<0.05 v all other groups.
†p<0.05 v saline. and myeloperoxidase activity, or the morphological appearance. Our data suggest that repair mechanisms began to operate on equivalently damaged tissues in both the CR group and the CR+CsA group, independent of cyclosporin administration. Moreover, our results do not fully support previously formulated hypotheses that conditioned collagen accumulation in the pancreas to a necrosisfibrosis sequence, 32 as both treatment regimens led to similar injury with a highly dissimilar outcome.
The pancreatic response to caerulein induced acute pancreatitis is characterised by inflammatory infiltrates, transient increase in TGF-expression, gland atrophy, collagen formation, fibroblast proliferation, and some acinar cell necrosis. [1] [2] [3] [4] [5] [6] Despite the extent of tissue damage, the pancreas regenerates completely leaving no signs of previous injury. Even repeated inductions of pancreatitis do not result in increased collagen deposition. 7 Therefore caerulein induced acute pancreatitis is a good reference model of adequate tissue repair.
Our data strongly suggest that cyclosporin acts to distort the normal pancreatic repair mechanisms that would have otherwise fully restored pancreatic morphology. The process is shown to be associated with steadily increased plasma levels of TGF-, myofibroblast proliferation, and a defective collagenase response to increased collagen formation.
Collagenase activity is expressed by extracellular matrix metalloproteinases that can be regulated by a number of cytokines such as interleukin 1 or TGF-. [33] [34] [35] The main sources of collagenases are fibroblasts and neutrophils. 33 Both tissue collagenase activity and fibroblast dependent collagen synthesis can be modulated by TGF-. 36 Indeed, the multifunctional TGF-s family of cytokines play a central role in the regulation of the coordinated events that characterise optimal wound healing. [36] [37] [38] [39] However, tissue fibrosis is prone to develop in response to sustained production of TGF-. [37] [38] [39] This cytokine activates stellate cells and stimulates their diVerentiation into myofibroblasts in the liver, 36 40 inhibits matrix degrading proteases (collagenase I, II, and III), 35 41 and increases the production of collagenase inhibitors, facilitating fibrogenesis. 38 TGF-is also known to inhibit the growth of epithelial cells and to stimulate fibroblast proliferation, and has been implicated in the pathogenesis of fibrosis in a number of other organs such as the kidney, lung, skin, and arteries. 42 There are data suggesting that TGF-also modulates extracellular matrix formation in the pancreas. Thus, TGF-stimulates collagen synthesis from fibroblasts derived from human pancreas, 43 and transgenic mice overexpressing TGF-show accumulation of extracellular matrix in the pancreas and fibroblast proliferation. 44 Administration of a neutralising antibody against TGF-reduces fibronectin expression in rats with caerulein induced pancreatitis, 43 whereas intravenous infusion of excess TGF-leads to increased collagen deposition and gland atrophy in mice. 8 Moreover, TGF-expression seems to be enhanced in human pancreas with chronic pancreatitis. 45 46 We speculate that steady increased plasma levels of TGF-, induced by cyclosporin, may account for a number of our experimental findings such as parenchymal atrophy, defective collagenase activity, and myofibroblast proliferation. After induction of caerulein pancreatitis, TGF-expression in the pancreas has been reported to be transiently elevated in the form of either a sharp peak of 2-3 days duration 3 4 or as a double wave peak occurring during the first week. 5 Our data on plasma TGF-concentration after caerulein pancreatitis are in agreement with the above reports.
Cyclosporin is widely used in clinical practice, on account of its immunomodulatory properties. 11 47 In addition, cyclosporin increases plasma TGF-in humans and mice 13 14 and has been shown to promote fibrogenesis in kidney, heart, and gums. 19 20 In vitro, cyclosporin induces collagen synthesis in fibroblasts. 48 Cyclosporin toxicity to the pancreas is regarded to be of lesser relevance. Given for periods of weeks in large dose regimens, cyclosporin causes a reduction in stimulated pancreatic secretion and some acinar cell vacuolisation. However, no inflammatory reaction has been shown, 16 17 and our results corroborate this point.
We have found, however, that cyclosporin induces the expression of pancreatic -SMA in interstitial fibroblast-like cells (myofibroblasts) and stimulates their proliferation even in the absence of an inflammatory reaction. In the liver, myofibroblasts (fibroblast-like cells expressing -SMA) represent the activated form of stellate cells, the main cell type involved in the synthesis of extracellular matrix components. 49 In the pancreas, fibroblasts are involved in the reparative processes activated after caerulein induced acute pancreatitis and are known to proliferate after the initial injury. 6 The normal pancreas contains interstitial cells that express desmin and vimentin, intermediate filaments that are also present in hepatic stellate cells. 50 In fibroblast-like cells from human pancreas in culture, TGF-enhances expression of -SMA and collagen synthesis. 43 The basic nature of these observations has now been confirmed and expanded by other investigators who have renamed pancreatic myofibroblasts as activated stellate cells of the pancreas. 51 52 However, despite increased plasma TGFand myofibroblast transformation, we could not show any enhancement in pancreatic collagen deposition in response to cyclosporin alone. In our model, stimulation of extracellular matrix accumulation (fibrosis) required the participation of an additional aggressive factor, such as oedematous pancreatitis, a mild inflammatory disease. Under such combined conditions of injury and background cyclosporin, the normal pancreatic repair pattern characterised by a transient rise in plasma TGF-, myofibroblast proliferation, collagen generation, and collagenase activity was substituted by a pathological post-injury pattern of steady high plasma levels of TGF-, myofibroblast proliferation, increased collagen deposition, and inappropriate collagenase activation. The end result of this pathological process was that, instead of the customary restoration of normal pancreatic architecture expected after an acute caerulein challenge, there was a catastrophic disturbance of the regenerative sequence. The accentuated gland atrophy, persistent inflammatory reaction, and enhanced fibrosis formation brought about a morphological transformation that closely resembles human chronic pancreatic disease. 53 
